AI Verdict
AAPL has stronger fundamentals based on our AI analysis.
PCSA vs AAPL Fundamental Comparison
| Metric | PCSA | AAPL |
|---|---|---|
| Revenue | $0.0 | $143.8B |
| Net Income | $-13.6M | $42.1B |
| Net Margin | N/A | 29.3% |
| ROE | -243.2% | 47.7% |
| ROA | -173.6% | 11.1% |
| Current Ratio | 2.54x | 0.97x |
| Debt/Equity | 0.00x | 1.00x |
| EPS | $-10.36 | $2.84 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
PCSA vs AAPL: Frequently Asked Questions
Is PCSA or AAPL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), AAPL has stronger fundamentals. PCSA is rated STRONG SELL (87% confidence) while AAPL is rated BUY (87% confidence). This is not investment advice.
How does PCSA compare to AAPL fundamentally?
Processa Pharmaceuticals, Inc. has ROE of -243.2% vs Apple Inc.'s 47.7%. Net margins are N/A vs 29.3% respectively.
Which stock pays higher dividends, PCSA or AAPL?
PCSA has a dividend yield of N/A or no dividend while AAPL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in PCSA or AAPL for long term?
For long-term investing, consider that PCSA has STRONG SELL rating with 87% confidence, while AAPL has BUY rating with 87% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about PCSA vs AAPL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For PCSA vs AAPL, the AI consensus favors AAPL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.